Solvonis Therapeutics plc (LON:SVNS)
0.2960
+0.0260 (9.63%)
At close: Jan 23, 2026
55.79% (1Y)
| Market Cap | 20.15M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.59M |
| Shares Out | 6.81B |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 29,726,460 |
| Average Volume | 34,187,910 |
| Open | 0.2700 |
| Previous Close | 0.2700 |
| Day's Range | 0.2600 - 0.2960 |
| 52-Week Range | 0.1095 - 0.4000 |
| Beta | 1.57 |
| RSI | 55.34 |
| Earnings Date | Apr 15, 2026 |